NorthStar Healthcare Income, Inc. financial data

Symbol
NHHS on OTC
Location
575 Lexington Avenue 14 Th St, 14 Th Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 431 % -20.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 186M shares 0%
Common Stock, Shares, Outstanding 186M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 1.86M USD 0%
Weighted Average Number of Shares Outstanding, Basic 186M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 186M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 211M USD +3.58%
General and Administrative Expense 12M USD -9.59%
Costs and Expenses 241M USD -17.5%
Income Tax Expense (Benefit) 82K USD +3.8%
Earnings Per Share, Basic 1 USD/shares
Earnings Per Share, Diluted 1 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 323M USD +299%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Assets 1.06B USD +1.94%
Liabilities 821M USD -10.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.48B USD +7.09%
Stockholders' Equity Attributable to Parent 238M USD +90.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 236M USD +90.7%
Liabilities and Equity 1.06B USD +1.94%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.26M USD +683%
Net Cash Provided by (Used in) Financing Activities -83.5M USD -444%
Net Cash Provided by (Used in) Investing Activities 85.7M USD +891%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 186M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.44M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 362M USD +315%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.96M USD -8.27%
Deferred Tax Assets, Valuation Allowance 17.4M USD +3.84%
Deferred Tax Assets, Gross 17.4M USD +3.84%
Depreciation 35M USD -6.42%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 98M USD +88.7%
Deferred Tax Assets, Operating Loss Carryforwards 16.5M USD +2.55%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 35.2M USD -6.83%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 248K USD +9.7%
Interest Expense 51.5M USD +16.2%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%